论文部分内容阅读
目的:57例宫颈腺癌的研究旨在分析宫颈腺癌的病理诊断要点及鉴别诊断。方法:采用回顾性方法总结57例宫颈腺癌的病理组织学特点,部分病例作了免疫组织化学和特殊染色。其中33例进行了长期随访并分析了预后与组织类型和临床分期的关系。结果:宫颈腺癌与非癌性增生的区别要根据多标准综合分析。PAS、Vimentin免疫标记在鉴别宫颈子宫内膜样腺癌和宫体子宫内膜腺癌方面有意义。结论:宫颈腺癌的5年生存率与宫颈腺癌类型和临床分期有关。
Objective: The study of 57 cases of cervical adenocarcinoma aims to analyze the pathological diagnosis of cervical adenocarcinoma and differential diagnosis. Methods: The histopathological features of 57 cases of cervical adenocarcinoma were retrospectively reviewed. Some cases were immunohistochemically and specially stained. Of these, 33 were followed up for a long period of time and the relationship between prognosis and tissue type and clinical stage was analyzed. Results: The difference between cervical adenocarcinoma and non-cancerous hyperplasia was based on multi-criteria comprehensive analysis. PAS, Vimentin immunolabeling in the differential diagnosis of cervical endometrial adenocarcinoma and uterine endometrial adenocarcinoma significance. Conclusion: The 5-year survival rate of cervical adenocarcinoma is related to the type of cervical adenocarcinoma and clinical stage.